DNA Sequencing Market Regional Analysis:
North America Market Insights
North America industry is predicted to hold largest revenue share of 51.5% by 2035. The key drivers are the large number of investments in research & development, the presence of key industry players, robust research infrastructure, technological innovations, and increasing applications in clinical practice.
The U.S. market is poised to account for a significant share during the forecast period. During the pandemic, the government invested USD 1.7 billion to increases the genomic sequencing of the country. In 2022, research published by scientists at Stanford sequenced a human genome in 5 hours and 2 minutes. This was the fastest sequencing in human history. Such innovations and government funding to boost the research ecosystem are conducive for market growth. Leading players in the U.S. market are also regularly launching new products owing to a robust regulatory panel thereby boosting the market growth.
In Canada, the government has made considerable efforts to boost genomic research. In October 2023, the Minister of Health announced a USD 15 million investment to establish a Pan-Canadian Genome Library to streamline genomic data sharing across the nation. The country also boasts some of the best sequencing facilities such as Donnely Sequencing Centre, StemCore Laboratories, and Michael Smith Genome Sciences Center among others. Increased focus on precision healthcare, greater investments in genome research, and an innovation-driven approach are key drivers to the market growth in Canada.
Asia Pacific Market Insights
The DNA sequencing market in Asia Pacific is poised to grow at the fastest rate during the forecast period owing to greater investments in research and the need for advanced healthcare for a large proportion of the population. Additionally, governments in countries such as South Korea, India, China, and Japan have funded national genome research projects to maintain a national database that will streamline the diagnostics for precision medicine.
In India, the DNA sequencing market is expected to drastically increase during the forecast period. A key driver is the increased research funding for the development of DNA sequencing. As per a Human Genomics report in 2019, there are 64.4 genetic defects per 1000 live births in the country. As per a report by Globocan in 2022, cancer cases in India will see a 57.5 increase by 2040 in India. The rising trajectory of diseases increases the demand for advanced genome sequencing data, evident from government initiatives, including, GenomeIndia.
China has the largest DNA sequencing market share in Asia Pacific. As per an NLM report, China’s Beijing Genomics Institute is the currently largest NGS sequencing center in the world after purchasing 128 new HiSeq 2000 genome sequences from Illumina. Recent trends indicate a significant boost in genome research such as the sequencing of giant pandas. In 2024, researchers in China unveiled the first complete genome of a Han Chinese, a landmark event in representation of Asian genome data.
